Avant Genomics
About
Avant Genomics, founded in early 2023 by two pioneering inventors from the University of Virginia’s renowned microfluidics lab, is revolutionizing the future of cancer detection. Initially developed in the laboratory of Dr. James Landers, Avant Genomics is creating an advanced platform for automated liquid biopsy sample preparation, designed to enhance the detection of cancer from circulating tumor DNA.
Sector
Devices & Instrumentation
Company Stage
Early Stage
Funding Sources
- Competition Awards
- Grants
- Private Investment
- Venture Capital
Company Size
4